DIFFRACTION OF BACTERIAL ENDOTOXINS: STRUCT BASED DRUG DESIGN, SCREEN PCP ENZYME
细菌内毒素的衍射:基于结构的药物设计,筛选 PCP 酶
基本信息
- 批准号:6220476
- 负责人:
- 金额:$ 1.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-08-15 至 2000-08-14
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Delta endotoxins are the entomocidal agent produced by Bacillus
thuringiensis ssp. Kurstaki. These toxins are produced as protoxins
(135 kDa) by the bacteria during sporulation and recognized by their
bipyrimidal crystalline form in the sporangium. When ingested by
larval Lepidoptera the crystal dissolves and is proteolytically
digested to the active toxin form (60-65 kDa). This activated toxin
is capable of opening K+ channels in the epithelium of the insect
midgut. Ion leakage ultimately results in the complete disruption of
the midgut and death of the insect. More recently, a new active form
of the toxin, CryIIIB2, has been determined (64 kDa). The bacterial
endotoxin CryIIIB2 is a 652 residue protein which crystallizes in the
orthorhombic space group C2221 with unit cell dimensions a = 122.44, b
= 131.81, and c = 105.37& and contain one molecule in the asymmetric
unit. Synchrontron radiation was used to collect 2.2& resolution data
at the CHESS facility at Cornell University in December, 1997 by
Vivian Cody and Nikolai Galitsky for the complex of EC11095 with
D-galactosamine. Although these data were did not diffract uniformly
to high resolution, Walt Pangborn was able to scale data with at least
50% completion for all shells to 2.2& resolution. The structure of
the native CryIIIB2 was used as a search model for the rotation and
translation function in the program XPLOR which revealed there was no
significant change in the molecular orientation of the molecule
compared to the room temperature model. The major consequence of low
temperature data collection is the contraction of the unit cell along
the a and b lattice directions. Interpretation of the difference
electron density maps made from the 3.0& refinement model of the
Arg-348 mutant of CryIIIB2 revealed a large density profile that
clearly was not a cluster of solvent and that could be fit to the
sugar. These data reveal that the galactosamine is positioned at the
intersection of the three domains of CryIIIB2. Refinement of these
data to 2.2& resolution suggest other potential sugar binding sites
are possible.
Delta内毒素是芽孢杆菌产生的杀虫物质
苏云金杆菌SSP.库尔斯塔基。这些毒素以原毒素的形式产生
(135 KDa)被细菌在产孢子过程中识别并被它们的
孢子囊中的双锥体晶形。当被摄取时
鳞翅目幼虫晶体溶解并蛋白降解
被消化成活性毒素形式(60-65 kDa)。这种被激活的毒素
能够打开昆虫上皮中的K+通道
中肠。离子泄漏最终会导致核辐射的完全破坏
昆虫的中肠和死亡。最近,一种新的活动表单
已确定该毒素为CryIIIB2(KDa)。细菌
内毒素CryIIIB2是一种由652个残基组成的蛋白质。
晶胞尺寸a=122.44,b的正交空间群C2221
=131.81,c=105.37,并且包含一个不对称分子
单位。使用同步辐射收集2.2分辨率的数据
1997年12月在康奈尔大学的国际象棋设施被
维维安·科迪和尼古拉·加利茨基为EC11095和
D-氨基半乳糖。尽管这些数据并不均匀地衍射化
为了达到高分辨率,沃尔特·庞伯恩能够用至少
完成50%的所有炮弹到2.2和分辨率。的结构
使用本地的CryIIIB2作为旋转和
程序XploR中的翻译功能显示没有
分子的分子取向发生重大变化
与室温模型进行了比较。Low的主要后果
温度数据采集是单位电池沿距离的收缩
A和b晶格方向。对差异的解释
从3.0版制作的电子密度图&精化模型
CryIIIB2的Arg-348突变体显示出较大的密度分布
显然不是一簇溶剂,这可以适用于
糖。这些数据表明,氨基半乳糖位于
CryIIIB2的三个结构域的交集。对这些进行改进
到2.2和分辨率的数据表明了其他潜在的糖结合位点
都是可能的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vivian Cody其他文献
Vivian Cody的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vivian Cody', 18)}}的其他基金
STRUCTURAL STUDIES OF AIDS-RELATED ENZYMES AND OTHER PATHOGENIC TARGETS
艾滋病相关酶和其他致病靶标的结构研究
- 批准号:
8362410 - 财政年份:2011
- 资助金额:
$ 1.38万 - 项目类别:
PROTEIN-PROTEIN INTERACTIONS OF DIHYDROFOLATE REDUCTASE
二氢叶酸还原酶的蛋白质-蛋白质相互作用
- 批准号:
6977201 - 财政年份:2004
- 资助金额:
$ 1.38万 - 项目类别:
DIFFRACTION OF BACTERIAL ENDOTOXINS: STRUCT BASED DRUG DESIGN, SCREEN PCP ENZYME
细菌内毒素的衍射:基于结构的药物设计,筛选 PCP 酶
- 批准号:
6667781 - 财政年份:2002
- 资助金额:
$ 1.38万 - 项目类别:
DIFFRACTION OF BACTERIAL ENDOTOXINS: STRUCT BASED DRUG DESIGN, SCREEN PCP ENZYME
细菌内毒素的衍射:基于结构的药物设计,筛选 PCP 酶
- 批准号:
6491104 - 财政年份:2001
- 资助金额:
$ 1.38万 - 项目类别:
DIFFRACTION OF BACTERIAL ENDOTOXINS: STRUCT BASED DRUG DESIGN, SCREEN PCP ENZYME
细菌内毒素的衍射:基于结构的药物设计,筛选 PCP 酶
- 批准号:
6339116 - 财政年份:2000
- 资助金额:
$ 1.38万 - 项目类别:
相似海外基金
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10448926 - 财政年份:2021
- 资助金额:
$ 1.38万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10491861 - 财政年份:2021
- 资助金额:
$ 1.38万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10675535 - 财政年份:2021
- 资助金额:
$ 1.38万 - 项目类别:
EPSRC Centre for Doctoral Training in Bioprocess Engineering Leadership (Complex Biological Products Manufacture)
EPSRC 生物过程工程领导力博士培训中心(复杂生物制品制造)
- 批准号:
EP/S021868/1 - 财政年份:2019
- 资助金额:
$ 1.38万 - 项目类别:
Training Grant
Exploring interactions and benefits of novel microbial biological products in blueberry propagation
探索新型微生物生物制品在蓝莓繁殖中的相互作用和益处
- 批准号:
529840-2018 - 财政年份:2018
- 资助金额:
$ 1.38万 - 项目类别:
Applied Research and Development Grants - Level 1
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403724 - 财政年份:2014
- 资助金额:
$ 1.38万 - 项目类别:
Standard Grant
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403697 - 财政年份:2014
- 资助金额:
$ 1.38万 - 项目类别:
Standard Grant
Formulation and delivery approaches for water soluble biological products delivered through the skin focussing on L-Ascorbic Acid.
通过皮肤输送的水溶性生物产品的配方和输送方法,重点是 L-抗坏血酸。
- 批准号:
131690 - 财政年份:2014
- 资助金额:
$ 1.38万 - 项目类别:
Feasibility Studies
Formulation and stability of biological products for skin delivery focussing on Retinol.
以视黄醇为重点的皮肤输送生物制品的配方和稳定性。
- 批准号:
131338 - 财政年份:2013
- 资助金额:
$ 1.38万 - 项目类别:
Feasibility Studies
Demonstrate the effectiveness of antimicrobial protection of new types of Biological Products
展示新型生物制品抗菌保护的有效性
- 批准号:
429734-2011 - 财政年份:2012
- 资助金额:
$ 1.38万 - 项目类别:
Experience Awards (previously Industrial Undergraduate Student Research Awards)














{{item.name}}会员




